NCT04902040 2026-03-18
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of California, San Francisco
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center